Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons
I give below details of an increase in interests in Ordinary shares in GlaxoSmithKline plc purchased at a price of £11.75 per share on 13 July 2010, and Ordinary share ADRs in GlaxoSmithKline plc purchased at a price of $34.12 per ADR on 13 July 2010, in respect of the personal holdings of the under-mentioned persons following the re-investment of the dividend paid to shareholders on 8 July 2010.
|
Ordinary shares |
ADRs |
Dr M M Slaoui |
159.45 |
159.57 |
Mrs C E Bruck Slaoui |
32.71 |
5.60 |
Mr J M Clarke |
401.99 |
|
Mr M Dunoyer |
192.20 |
|
Mr E J Gray |
226.97 |
|
Mr W C Louv |
|
124.50 |
Mr D J Phelan |
|
304.25 |
Dr D Pulman |
|
187.24 |
Mr D S Redfern |
122.89 |
|
Mr J R Stéphenne |
594.80 |
|
Ms C Thomas |
93.02 |
|
Mr P J T Vallance |
55.64 |
|
The Company was advised of this information on 14 July 2010.
This notification relates to a transaction notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).
S M Bicknell
Company Secretary
14 July 2010